Levena Biopharma is a global ADC CRO/CDMO dedicated to advancing Antibody Drug Conjugate programs from discovery to the clinic and beyond. In 2013, Sorrento acquired Concortis Biosystems, establishing Levena as an independent, wholly-owned subsidiary of Sorrento Therapeutics to offer the scientific community access to our leading-edge linkers, payloads, and site-specific conjugation technologies.
Our mission is to collaboratively develop conjugates that maximize the therapeutic potential of our clients' native or engineered antigen-targeting biomolecular carriers (antibodies, proteins and nucleic acids) and advance precision medicine options for patients with unmet clinical needs.
We welcome discussing your projects and our capabilities at our world-class facilities in:
-- San Diego (R&D Headquarters, 2013)
-- Suzhou (CMC and cGMP, 2017)
Levena provides small and large scale proof-of-concept (POC) conjugation services as well as complete ADC characterization using advanced analytical tools such as HPLC (HIC, SEC, RP), iCIEF and LC-MS, quality assessment (Drug-to-Antibody Ratio, purity via SDS-PAGE, aggregation, endotoxin, residual drug) and in vitro pharmacology for cytotoxicity studies.
Expanding on IP from Concortis starting in 2008, we continue to maintain and grow our comprehensive, in-house portfolio of leading-edge ADC solutions, enabling Levena's world-class chemistry & conjugation teams to efficiently deliver constructs with unsurpassed quality and therapeutic potential.
Our proprietary and non-proprietary ADC solutions include Linkers, Payloads, L-P chemistries and site-specific conjugation platforms [C-Lock™, K-Lock™ and C-Lock™/K-Lock™ for dual-drug delivery], enabling efficient development of mechanistically-defined ADCs with exacting, reproducible performance for safety, efficacy and clinical success.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 4955 Directors Place, Suite 300,china
- Phone
- 1 (858) 203-4200
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- levena.cn
- Keywords
- Contract research organization, cGMP Production, Antibody drug conjugation, Linkers & Toxins, Conjugation and analytical services.
- HQ
- San Diego, CA
Levena Biopharma Questions
Levena Biopharma's helpline number is 1 (858) 203-4200
Levena Biopharma's website is levena.cn
Levena Biopharma's LinkedIn profile is https://www.linkedin.com/company/levena-biopharma-co-ltd
Levena Biopharma has
11 employees.
View email and phone details for 11
employees at Levena Biopharma.
Levena Biopharma's industry is
Pharmaceutical Manufacturing
Levena Biopharma's top competitors are
Innovent Biologics,
Ngm Biopharmaceuticals,
Genentech,
Light Horse Therapeutics,
Exelixis,
Sorrento Therapeutics, Inc.,
Poseida Therapeutics, Inc.,
Adcentrx Therapeutics,
Adagene,
Blossomhill Therapeutics, Inc..
Levena Biopharma's support email address is info@levenabiopharma.com
Levena Biopharma's categories are Pharmaceutical Manufacturing
Levena Biopharma's founding year is 2013
